×
About 309 results

ALLMedicine™ Factor X Deficiency Center

Research & Reviews  147 results

Management of Factor X Deficiency for Vaginal Delivery in a Parturient: A Case Report.
https://doi.org/10.1213/XAA.0000000000001405
A&A Practice; Yen CB, Katz DJ

Feb 12th, 2021 - Factor X (FX) deficiency is a rare coagulopathy that may cause bleeding complications in parturients. The literature on rotational thromboelastometry (ROTEM; Instrumentation Laboratory, Bedford, MA) to guide factor repletion and neuraxial placemen...

Use of plasma-derived factor X concentrate in neonates and infants with congenital fact...
https://doi.org/10.1111/jth.14985
Journal of Thrombosis and Haemostasis : JTH; Zimowski KL, McGuinn CE et. al.

Jul 2nd, 2020 - Congenital factor X deficiency (FXD) is a rare bleeding disorder that often presents with severe bleeding in the neonatal period. Long-term prophylaxis with infusions of FX-containing products is recommended in patients with FXD and a personal or ...

"I have been refused to be treated by three dentists": Barriers to patient care.
https://doi.org/10.1111/scd.12463
Special Care in Dentistry : Official Publication of the A... Abed H, Abuljadayel J

May 1st, 2020 - Factor X deficiency (known as; Stuart-Prower factor deficiency or F10 deficiency) is a rare inherited bleeding disorder. It affects one per 1 million individuals worldwide. Patients with inherited bleeding disorder reported difficulty in accessing...

Factor X Deficiency Management for Elective Cesarean Delivery in a Pregnant Patient.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117852
The American Journal of Case Reports; Krkovic M, Koosova Gajic A et. al.

Mar 18th, 2020 - BACKGROUND Congenital factor X deficiency is a rare inherited coagulopathy. Pregnancies in women with this disorder are often associated with adverse outcomes, including miscarriage, premature labor, and hemorrhage during pregnancy and in the peri...

Factor X Deficiency
https://emedicine.medscape.com/article/209867-overview

Feb 17th, 2020 - Practice Essentials Clotting factor X, or Stuart-Prower factor, is a vitamin K–dependent serine protease that serves as the first enzyme in the common pathway of thrombus formation. Factor X deficiency is a bleeding disorder that can be inherited ...

see more →

Drugs  2 results see all →

Clinicaltrials.gov  153 results

Management of Factor X Deficiency for Vaginal Delivery in a Parturient: A Case Report.
https://doi.org/10.1213/XAA.0000000000001405
A&A Practice; Yen CB, Katz DJ

Feb 12th, 2021 - Factor X (FX) deficiency is a rare coagulopathy that may cause bleeding complications in parturients. The literature on rotational thromboelastometry (ROTEM; Instrumentation Laboratory, Bedford, MA) to guide factor repletion and neuraxial placemen...

Use of plasma-derived factor X concentrate in neonates and infants with congenital fact...
https://doi.org/10.1111/jth.14985
Journal of Thrombosis and Haemostasis : JTH; Zimowski KL, McGuinn CE et. al.

Jul 2nd, 2020 - Congenital factor X deficiency (FXD) is a rare bleeding disorder that often presents with severe bleeding in the neonatal period. Long-term prophylaxis with infusions of FX-containing products is recommended in patients with FXD and a personal or ...

"I have been refused to be treated by three dentists": Barriers to patient care.
https://doi.org/10.1111/scd.12463
Special Care in Dentistry : Official Publication of the A... Abed H, Abuljadayel J

May 1st, 2020 - Factor X deficiency (known as; Stuart-Prower factor deficiency or F10 deficiency) is a rare inherited bleeding disorder. It affects one per 1 million individuals worldwide. Patients with inherited bleeding disorder reported difficulty in accessing...

Factor X Deficiency Management for Elective Cesarean Delivery in a Pregnant Patient.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117852
The American Journal of Case Reports; Krkovic M, Koosova Gajic A et. al.

Mar 18th, 2020 - BACKGROUND Congenital factor X deficiency is a rare inherited coagulopathy. Pregnancies in women with this disorder are often associated with adverse outcomes, including miscarriage, premature labor, and hemorrhage during pregnancy and in the peri...

Factor X Deficiency
https://emedicine.medscape.com/article/209867-overview

Feb 17th, 2020 - Practice Essentials Clotting factor X, or Stuart-Prower factor, is a vitamin K–dependent serine protease that serves as the first enzyme in the common pathway of thrombus formation. Factor X deficiency is a bleeding disorder that can be inherited ...

see more →

News  7 results

Product can reduce, prevent bleeding in kids with FXD
https://www.mdedge.com/hematology-oncology/article/185555/thrombosis/product-can-reduce-prevent-bleeding-kids-fxd
HT Staff

Jul 20th, 2017 - Vials and a syringe BERLIN—Results of a phase 3 study suggest prophylaxis with plasma-derived factor X (pdFX, Coagadex®) prevents or reduces bleeding episodes in children with moderate to severe hereditary factor X deficiency (FXD). pdFX was well.

EMA recommends therapy for bleeding disorder
https://www.mdedge.com/hematology-oncology/article/188481/pharmacy/ema-recommends-therapy-bleeding-disorder
HT Staff

Feb 8th, 2016 - Drug vials and a syringe The European Medicines Agency (EMA) has recommended marketing authorization for Coagadex to treat hereditary factor X deficiency, a rare bleeding disorder. The active substance in Coagadex is coagulation factor X, a protei.

FDA approves factor X concentrate
https://www.mdedge.com/hematology-oncology/article/187532/thrombosis/fda-approves-factor-x-concentrate
HT Staff

Oct 22nd, 2015 - Vials and a syringe The US Food and Drug Administration (FDA) has approved a factor X product derived from human plasma (Coagadex) to treat patients with hereditary factor X deficiency who are 12 years of age and older. Coagadex is approved for on.

FDA Approves Factor X Replacement
https://www.medpagetoday.com/hematologyoncology/hematology/54196

Oct 20th, 2015 - The first replacement therapy for hereditary Factor X deficiency, derived from human plasma and trade-named Coagadex, won approval from the FDA Tuesday. "Until today's orphan drug approval, no specific coagulation factor replacement therapy was av...

see more →